High-Stim Thermogenic Fat Burner
This injectable form was first approved by the FDA in December 2017 for the treatment of type 2 diabetes, reducing the risk of major cardiovascular events in patients with type 2 diabetes and cardiovascular disease, and reducing the risk of kidney disease progression and cardiovascular death in patients with type 2 diabetes and chronic kidney disease

Vial 10 mg Tesamorelin Vial 10mg Tesamorelin Vial 50 mg KLOW Vial GHK-Cu, BPC-157, TB-500, KPV Vial 20 mg Thymalin Vial 20mg Thymalin (thymus polypeptide fraction) Vial 10 mg TB-500 Vial 10mg TB-500 (Thymosin Beta-4) Vial 10 mg Semax Vial 10mg Semax Vial 10 mg Selank Vial 10mg Selank Vial 10 mg MOTS-c Vial 10mg MOTS-c Vial 8 mg Ipamorelin Vial 8mg Ipamorelin Vial 20 mg GLOW Vial GHK-Cu, BPC-157, TB-500 Vial 50 mg GHK-Cu Vial 50mg GHK-Cu (Copper Peptide) Vial 10 mg FOXO4-DRI Vial 10mg FOXO4-DRI Vial 10 mg Epitalon Vial 10mg Epitalon Vial 5 mg DSIP Vial 5mg DSIP (Delta Sleep-Inducing Peptide) Vial 5 mg CJC-1295 with DAC Vial 5mg CJC-1295 DAC Vial 8 mg CJC-1295 + Ipamorelin Vial 16mg CJC-1295, Ipamorelin Vial 10 mg BPC-157 Vial 10mg BPC-157 Vial 5 mg AOD-9604 Vial 5mg AOD-9604 Vial 10 mg Kisspeptin-10 Vial 10mg Kisspeptin-10 Vial 20 mg Cartalax Peptide 20mg Cartalax (Ala-Glu-Asp)
What if I accidentally shook the vial
If you want to better understand how these medications fit into treatment plans, read more about how semaglutide is prescribed
Pappachan Chronic Diseases and Translational Medicine.2026